Potassium Ion

Potassium Ion

SCHEMBL2866209

CC(C)(C)[O-].[K+].[NaH]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL41 0.94
Potassium Ion SCHEMBL14630574 0.94 TSHR (0.30)
Potassium Ion SCHEMBL4441965 0.88
Ammonia Solution, Strong SCHEMBL545541 0.88
Potassium Ion SCHEMBL3178692 0.88
Potassium Ion SCHEMBL9325821 0.88
Potassium Ion SCHEMBL21360011 0.88
Water SCHEMBL182730 0.88
SCHEMBL22800862 0.88
Potassium Ion SCHEMBL8645894 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117510332-A New method for synthesizing 6, 8-dichloro octanoic acid ester 风火轮(上海)生物科技有限公司 2024-02-06 CN claimed
CN-116903500-A Method for synthesizing p-methylsulfonyl benzaldehyde 上海颐碳化学科技有限公司 2023-10-20 CN claimed
CN-116396205-A N-aryl indole derivative and preparation method and application thereof 沈阳药科大学 2023-07-07 CN claimed
CN-115650983-A Synthesis method of entecavir intermediate N4 南京康立瑞生物科技有限公司 2023-01-31 CN claimed
CN-115010623-A Preparation method of 2-cyanoethyl diethyl malonate 福建科宏生物工程股份有限公司 2022-09-06 CN claimed
WO-2022101939-A1 NOVEL PROCESS FOR THE PREPARATION OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE OR ITS SALTS THEREOF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2022-05-19 WO claimed
EP-3041832-A1 STEREOSELECTIVE SYNTHESIS OF DIOLS AND TRIOLS BY MANNICH REACTION AND THEIR USE IN THE SYNTHESIS OF CARFILZOMIB Sandoz AG (CH) 2016-07-13 EP claimed
US-20160194354-A1 STEREOSELECTIVE SYNTHESIS OF DIOLS AND TRIOLS BY MANNICH REACTION AND THEIR USE IN THE SYNTHESIS OF CARFILZOMIB SANDOZ GMBH (AT) 2016-07-07 US claimed
WO-2015162506-A1 PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND NOVEL INTERMEDIATES SUVEN LIFE SCIENCES LIMITED (IN) 2015-10-29 WO claimed
WO-2015032622-A1 STEREOSELECTIVE SYNTHESIS OF DIOLS AND TRIOLS BY MANNICH REACTION AND THEIR USE IN THE SYNTHESIS OF CARFILZOMIB SANDOZ AG (CH) 2015-03-12 WO claimed
EP-2168969-A2 Racemization and Enantiomer Separation of Clopidogrel TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2010-03-31 EP claimed
EP-1483269-B1 RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL TEVA PHARMA (IL) 2009-10-14 EP claimed
EP-1483269-A1 RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL Teva Pharmaceutical Industries Limited (IL) 2004-12-08 EP claimed
WO-2004013147-A1 RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-02-12 WO claimed
CN-117510332-A New method for synthesizing 6, 8-dichloro octanoic acid ester 风火轮(上海)生物科技有限公司 2024-02-06 CN disclosed
CN-116903500-A Method for synthesizing p-methylsulfonyl benzaldehyde 上海颐碳化学科技有限公司 2023-10-20 CN disclosed
CN-116396205-A N-aryl indole derivative and preparation method and application thereof 沈阳药科大学 2023-07-07 CN disclosed
WO-2004013147-A1 RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-02-12 WO disclosed
US-20040024012-A1 Racemization and enantiomer separation of clopidogrel TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2004-02-05 US disclosed
US-20040024011-A1 RACEMIZATION AND ENANTIOMER SEPARATION OF CLOPIDOGREL TEVA PHARMACEUTICALS USA, INC. 2004-02-05 US disclosed